Perspective on emerging biomarker-driven therapies in gastric cancer, FGFR2 and beyond

被引：0
|
作者：
Wainberg, Zev A. [1 ]
机构：
[1] UCLA, Ronald Reagan UCLA Med Ctr, Med Ctr, Santa Monica, CA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PSY03-2
引用
收藏
页码：S1355 / S1355
页数：1
相关论文
共 50 条
  • [1] Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
    Mishra, Prachi
    Laha, Dipranjan
    Grant, Robert
    Nilubol, Naris
    CANCERS, 2021, 13 (24)
  • [2] Neutralizing antibody to FGFR2 can act as a selective biomarker and potential therapeutic agent for gastric cancer with FGFR2 amplification
    Kim, Seung Tae
    Lee, In Kyoung
    Rom, Eran
    Sirkis, Roy
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Kyoung-Mee
    Yayon, Avner
    Lee, Jeeyun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (07): : 4508 - 4515
  • [3] Challenges of FGFR2 Testing in Gastric Cancer
    Tsimafeyeu, Ilya
    Raskin, Grigory
    ONCOLOGY REVIEWS, 2023, 17
  • [4] Investigating FGFR2 gene as a blood-based epigenetic biomarker in gastric cancer
    Aleyasin, Seyed Ahmad
    Moradi, Arash
    Abolhasani, Naeimeh
    Abdollahi, Mahvash
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [5] Biomarker-driven targeted therapies for gastric/gastro-esophageal junction malignancies
    Kim, Salem
    Barzi, Afsaneh
    Rajdev, Lakshmi
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 133 - 150
  • [6] Frequency of FGFR2 gene amplification in gastric cancer
    Matsumoto, Kazuko
    Arao, Tokuzo
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    Kato, Ken
    Oda, Ichiro
    Taniguchi, Hirokazu
    Koizumi, Fumiaki
    Yanagihara, Kazuyoshi
    Sasaki, Hiroki
    Yamada, Yasuhide
    Nishio, Kazuto
    CANCER RESEARCH, 2012, 72
  • [7] Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
    Giovanni Brandi
    Valeria Relli
    Marzia Deserti
    Andrea Palloni
    Valentina Indio
    Annalisa Astolfi
    Salvatore Serravalle
    Alessandro Mattiaccio
    Francesco Vasuri
    Deborah Malvi
    Chiara Deiana
    Maria Abbondanza Pantaleo
    Matteo Cescon
    Alessandro Rizzo
    Masaru Katoh
    Simona Tavolari
    Scientific Reports, 14
  • [8] Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
    Brandi, Giovanni
    Relli, Valeria
    Deserti, Marzia
    Palloni, Andrea
    Indio, Valentina
    Astolfi, Annalisa
    Serravalle, Salvatore
    Mattiaccio, Alessandro
    Vasuri, Francesco
    Malvi, Deborah
    Deiana, Chiara
    Pantaleo, Maria Abbondanza
    Cescon, Matteo
    Rizzo, Alessandro
    Katoh, Masaru
    Tavolari, Simona
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers
    Harris, William R.
    Wong, Kit Man
    Saha, Supriya
    El Dika, Imane
    Abou-Alfa, Ghassan K.
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 116 - 123
  • [10] Novel therapies in urothelial carcinoma: a biomarker-driven approach
    Iyer, G.
    Rosenberg, J. E.
    ANNALS OF ONCOLOGY, 2018, 29 (12) : 2302 - 2312
12345